Characteristics |
Treated
(n=61) |
Non-treated
(n=10) |
p |
Age (years) |
|
|
0.905# |
Mean ± SD |
40 ± 15 |
39 ± 16 |
|
Gender |
|
|
0.718## |
Male |
42 (68.9%) |
6 (60.0%) |
|
Female |
19 (31.1%) |
4 (40.0%) |
|
Etnia |
|
|
0.149## |
Caucasian |
37 (63.8%) |
9 (90.0%) |
|
Non Caucasian |
21 (36.2%) |
1 (10.0%) |
|
Weight (kg) |
|
|
0.608# |
Mean ± SD |
71.6 ± 13.5 |
74.9 ± 19.1 |
|
Time (months) since symptoms onset until renal biopsy |
|
|
0.406### |
Median (min – max) |
6.5 (1 – 108) |
4.0 (1 – 36) |
|
Comorbidities |
|
|
>0.999#### |
Without coexisting diseases |
52 (85.2%) |
10 (100.0%) |
|
Schistosomiasis |
2 (3.3%) |
- |
|
Hypothiroidism |
4 (6.6%) |
- |
|
Diabetes mellitus |
3 (4.9%) |
- |
|
Hypertension |
|
|
0.735## |
Yes |
31 (50.8%) |
4 (40.0%) |
|
No |
30 (49.2%) |
6 (60.0%) |
|
Hematuria |
|
|
>0.999## |
Yes |
47 (77.0%) |
8 (80.0%) |
|
No |
14 (23.0%) |
2 (20.0%) |
|
Proteinuria |
|
|
0.013## |
Nephrotic |
59 (96.7%) |
6 (66.7%) |
|
Non nephrotic |
2 (3.3%) |
3 (33.3%) |
|
Presentation syndrome |
|
|
0.034#### |
Nephrotic syndrome |
52 (85.2%) |
6 (66.7%) |
|
Nephrotic proteinuria |
2 (3.3%) |
- |
|
Non nephrotic proteinuria |
2 (3.3%) |
3 (33.3%) |
|
Initial proteinuria (g/24h) |
|
|
0.055### |
Median (min - max) |
6.4 (1.9 – 53.0) |
4.2 (0.6 – 11.0) |
|
Initial serum creatinine (mg/dl) |
|
|
0.418### |
Median (min - max) |
1.1 (0.4 – 3.4) |
0.9 (0.5 – 3.3) |
|
Initial serum albumin (mg/dl) |
|
|
0.181### |
Median (min - max) |
2.2 (0.8 – 3.8) |
2.5 (2.0 – 4.7) |
|
Time of follow-up (months) |
|
|
0.649### |
Median (min - max) |
34.0 (6 – 355) |
22.5 (9 – 223) |
|
